OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3
Nisintha Mahendrarajah, Marina E. Borisova, Sigrid Reichardt, et al.
Cellular Signalling (2017) Vol. 39, pp. 9-17
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

PGD2/PTGDR2 Signaling Restricts the Self-Renewal and Tumorigenesis of Gastric Cancer
Bin Zhang, Qingli Bie, Peipei Wu, et al.
Stem Cells (2018) Vol. 36, Iss. 7, pp. 990-1003
Open Access | Times Cited: 79

Loss of Long Noncoding RNANXTARin Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide Resistance
Ruchi Ghildiyal, Mithila Sawant, Arun Renganathan, et al.
Cancer Research (2021) Vol. 82, Iss. 1, pp. 155-168
Open Access | Times Cited: 41

SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis
Surbhi Chouhan, Dhivya Sridaran, Cody Weimholt, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7

Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes
Nicole Kiweler, Desirée Wünsch, Matthias Wirth, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 2, pp. 343-356
Open Access | Times Cited: 44

Activation of STAT transcription factors by the Rho-family GTPases
Jessica Corry, Helen R. Mott, Darerca Owen
Biochemical Society Transactions (2020) Vol. 48, Iss. 5, pp. 2213-2227
Open Access | Times Cited: 30

Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3‐mediated muscle wasting in cancer cachexia mice
Mengyuan Niu, Shiyu Song, Zhonglan Su, et al.
British Journal of Pharmacology (2021) Vol. 178, Iss. 22, pp. 4485-4500
Open Access | Times Cited: 23

Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting
Mithila Sawant, Kiran Mahajan, Arun Renganathan, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 649
Open Access | Times Cited: 18

Acetylated HOXB13 Regulated Super Enhancer Genes Define Therapeutic Vulnerabilities of Castration-Resistant Prostate Cancer
Duy T. Nguyen, Wei Yang, Arun Renganathan, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 18, pp. 4131-4145
Open Access | Times Cited: 16

Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy
Gaëtan Jégo, François Hermetet, François Girodon, et al.
Cancers (2019) Vol. 12, Iss. 1, pp. 21-21
Open Access | Times Cited: 29

The role of Siah2 in tumorigenesis and cancer therapy
Kailang Li, Jinyun Li, Meng Ye, et al.
Gene (2021) Vol. 809, pp. 146028-146028
Closed Access | Times Cited: 19

Myeloid Deletion of Cdc42 Protects Liver From Hepatic Ischemia-Reperfusion Injury via Inhibiting Macrophage-Mediated Inflammation in Mice
Jing He, Mengyu Tang, Li-Xin Liu, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 17, Iss. 6, pp. 965-981
Open Access | Times Cited: 2

The non-receptor tyrosine kinase ACK: regulatory mechanisms, signalling pathways and opportunities for attACKing cancer
Millie Fox, Claire Crafter, Darerca Owen
Biochemical Society Transactions (2019) Vol. 47, Iss. 6, pp. 1715-1731
Open Access | Times Cited: 22

Inhibition of Heat Shock Protein 90 as a Novel Platform for the Treatment of Cancer
Chang Gao, Yanan Peng, Haizhou Wang, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 8, pp. 849-855
Closed Access | Times Cited: 20

Identification of downstream signaling cascades of ACK1 and prognostic classifiers in non-small cell lung cancer
Jinhong Zhu, Yang Liu, Meng Zhao, et al.
Aging (2021) Vol. 13, Iss. 3, pp. 4482-4502
Open Access | Times Cited: 17

Paris saponins Ⅶ inhibits glycolysis of ovarian cancer via the RORC/ACK1 signaling pathway
Zong Wu, Chenyue Yuan, Zihao Zhang, et al.
Biochemical Pharmacology (2023) Vol. 213, pp. 115597-115597
Open Access | Times Cited: 6

Small Molecules Targeting Activated Cdc42-Associated Kinase 1 (ACK1/TNK2) for the Treatment of Cancers
Aoxue Wang, Junping Pei, Shuai Wen, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 22, pp. 16328-16348
Closed Access | Times Cited: 15

The discovery and maturation of peptide biologics targeting the small G-protein Cdc42: A bioblockade for Ras-driven signaling
George J.N. Tetley, Natasha P. Murphy, Stéphane Bonetto, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 9, pp. 2866-2884
Open Access | Times Cited: 14

STAT1 N-terminal domain discriminatively controls type I and type II IFN signaling
Anja Göder, Torsten Ginter, Thorsten Heinzel, et al.
Cytokine (2021) Vol. 144, pp. 155552-155552
Closed Access | Times Cited: 12

Grass carp (Ctenopharyngodon idella) TNK1 modulates JAK-STAT signaling through phosphorylating STAT1
Yapeng Liu, Hailing Du, Shanghong Wang, et al.
Developmental & Comparative Immunology (2020) Vol. 116, pp. 103951-103951
Closed Access | Times Cited: 12

LncRNA ZFPM2-AS1 promotes phyllodes tumor progression by binding to CDC42 and inhibiting STAT1 activation
Shishi He, Guowei Huang, Rong Lei, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2942-2958
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top